Home › Funds › Venrock Adviser, LLC › KRRO
Venrock Adviser, LLC position in KRRO
KORRO BIO INC · Health Care
Venrock Adviser, LLC reported holding 443,431 shares of KRRO (KORRO BIO INC) in its Q3 2026 13F filing — a position valued at US$4.4M, representing 0.21% of its reported portfolio and ranking #31 among its reported holdings. Venrock Adviser, LLC has disclosed KRRO holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Venrock Adviser, LLC's KRRO position evolved
Venrock Adviser, LLC first disclosed a stake in KRRO in Q1 2026 at 1,009,500 shares (US$11.4M). The position peaked in Q2 2026 at 1,009,500 shares, worth US$13.3M. Across 3 filings, Venrock Adviser, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 443,431 shares valued at US$4.4M — a reduction of -566,069 shares quarter over quarter.. Notable position changes include a 56% trim in Q3 2026 (shares rose 28% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 1.01M | $11.43M | New |
| Q2 2026 | 1.01M | $13.31M | Hold |
| Q3 2026 | 443.43K | $4.39M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KRRO and 13F data
KRRO (KORRO BIO INC) is a Health Care company. 30 other funds we track also report a position in KRRO — the largest reported positions include Lynx1 Capital Management LP (US$15.3M), NEA Management Company, LLC (US$12.9M), Atlas Venture Life Science Advisors, LLC (US$7.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KRRO
- Lynx1 Capital Management LP 1.54M sh · $15.31M · Q3 2026
- NEA Management Company, LLC 1.30M sh · $12.86M · Q3 2026
- Atlas Venture Life Science Advisors, LLC 773.26K sh · $7.66M · Q3 2026
- Kalehua Capital Management LLC 473.60K sh · $4.69M · Q3 2026
- TCG Crossover Management, LLC 416.30K sh · $4.13M · Q3 2026
- 72 Investment Holdings, LLC 276.83K sh · $2.74M · Q3 2026
More on Venrock Adviser, LLC
FAQ
How long has Venrock Adviser, LLC held KRRO?
Venrock Adviser, LLC has disclosed KRRO holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Venrock Adviser, LLC's current position in KRRO?
As of Q3 2026, Venrock Adviser, LLC holds 443.43K shares of KRRO (KORRO BIO INC), valued at $4.39M, representing 0.21% of its reported portfolio and ranking #31.
Has Venrock Adviser, LLC been buying or selling KRRO?
In the latest 13F filing (Q3 2026), Venrock Adviser, LLC reduced its position in KRRO. The position peaked in Q2 2026 at 1.01M shares.
Which other funds hold KRRO?
Other major institutional holders of KRRO include Lynx1 Capital Management LP, NEA Management Company, LLC, Atlas Venture Life Science Advisors, LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.